<DOC>
	<DOCNO>NCT00554164</DOCNO>
	<brief_summary>The main purpose PETAL trial determine whether patient aggressive non-Hodgkin 's lymphoma persistently positive PET scan two cycle chemotherapy benefit change treatment protocol .</brief_summary>
	<brief_title>Positron Emission Tomography Guided Therapy Aggressive Non-Hodgkin 's Lymphomas</brief_title>
	<detailed_description>Positron emission tomography perform two cycle ( R- ) CHOP chemotherapy ( interim-PET ) show predict long-term outcome patient aggressive non-Hodgkin 's lymphoma . Patients early normalization pathological PET finding excellent prognosis , patient persistently pathological PET scan high risk non-response relapse . Patients negative interim-PET scan ( part A trial ) randomize receive either another four cycle ( R- ) CHOP regimen ( arm A1 ) four cycle ( R- ) CHOP regimen plus two additional dos rituximab ( arm A2 ) . Randomisation part A trial stop number patient require reach ( 128 patient treatment arm ) . Since patient uniformly treat accord arm A2 . Patients persistently positive interim-PET scan ( part B trial ) randomize either continue treatment another six ( R- ) CHOP cycle ( arm B1 ) switch alternative protocol use treatment Burkitt 's lymphoma ( arm B2 : six block accord so-called B-ALL protocol German ALL study group ) . Patients refractory relapse within two year treatment accord part A B trial receive age-adapted salvage protocol ( patient &lt; 60 year : high-dose chemotherapy autologous stem cell transplantation ; patient &gt; 60 year : ( R- ) ESHAP protocol ) ( part C trial ) .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Aggression</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<criteria>Aggressive Bcell Tcell nonHodgkin 's lymphoma Pathological pretreatment PET scan Performance status ECOG 03 Age 18 80 year Ability understand purpose study act accordingly Willingness use adequate contraception Informed consent Burkitt 's lymphoma Primary central nervous system lymphoma Previous chemo and/or radiotherapy Other cancer within precede 5 year HIV infection , active viral hepatitis uncontrolled infection Other medical condition preclude administration plan therapy Pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Aggressive non-Hodgkin 's lymphoma</keyword>
	<keyword>Positron emission tomography</keyword>
	<keyword>Chemotherapy</keyword>
</DOC>